See also this year's filing and all EDGAR filings for this company.
PDF Report 0001720893_2020_Bioxcel_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001720893, Bioxcel Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,107,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,041,000 |
| 3 | remainder_Assets | 1,244,000 |
| 4 | LiabilitiesCurrent | 8,468,000 |
| 5 | LiabilitiesNoncurrent | 1,029,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,804,000 |
| 9 | ResearchAndDevelopmentExpense | 25,797,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 633,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 36,392,000 |
| 1 | Liabilities | 9,497,000 |
| 2 | Expenses | 33,601,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 26,895,000 |
| 5 | NetIncome | -32,968,000 |
| 6 | ComprehensiveNetIncome | -32,968,000 |
| 7 | BaseVar | 40,061,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.12 |
| 9 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
